BioCentury
ARTICLE | Analyst Picks & Changes

Analyst picks & changes

February 7, 1994 8:00 AM UTC

Amgen Inc.

Jeffrey Casdin of Oppenheimer & Co. changed his rating on Amgen Inc. to "market performer" from "buy," following publication of the company's fourth quarter earnings. He said the renewed near-term growth of ...